This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
BioLegend
other brands :
Babco, Signet, Sternberger Monoclonals, Senetek, Covance
product type :
ELISA/assay
product name :
Zombie Yellow™ Fixable Viability Kit
catalog :
423103
quantity :
100 tests
price :
83 USD
citations: 55
Reference
Wang X, Maxwell K, Wang K, Bowers D, Flanders J, Liu W, et al. A nanofibrous encapsulation device for safe delivery of insulin-producing cells to treat type 1 diabetes. Sci Transl Med. 2021;13: pubmed publisher
Ludwik K, Sandusky Z, Wright E, Lannigan D. FACS protocol for direct comparison of cell populations isolated from mice. STAR Protoc. 2021;2:100270 pubmed publisher
Zhang S, Iyer S, Ran H, Dolgalev I, Gu S, Wei W, et al. Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer. Cancer Discov. 2021;11:362-383 pubmed publisher
Huang N, Fan X, Zaleta Rivera K, Nguyen T, Zhou J, Luo Y, et al. Natural display of nuclear-encoded RNA on the cell surface and its impact on cell interaction. Genome Biol. 2020;21:225 pubmed publisher
Zhou T, Damsky W, Weizman O, McGeary M, Hartmann K, Rosen C, et al. IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy. Nature. 2020;583:609-614 pubmed publisher
Valbuena Perez J, Linnenberger R, Dembek A, Bruscoli S, Riccardi C, Schulz M, et al. Altered glucocorticoid metabolism represents a feature of macroph-aging. Aging Cell. 2020;19:e13156 pubmed publisher
Zhao B, Liu P, Fukumoto T, Nacarelli T, Fatkhutdinov N, Wu S, et al. Topoisomerase 1 cleavage complex enables pattern recognition and inflammation during senescence. Nat Commun. 2020;11:908 pubmed publisher
Fallet B, Hao Y, Florova M, Cornille K, de Los Aires A, Girelli Zubani G, et al. Chronic Viral Infection Promotes Efficient Germinal Center B Cell Responses. Cell Rep. 2020;30:1013-1026.e7 pubmed publisher
Jain A, Irizarry Caro R, McDaniel M, Chawla A, Carroll K, Overcast G, et al. T cells instruct myeloid cells to produce inflammasome-independent IL-1β and cause autoimmunity. Nat Immunol. 2020;21:65-74 pubmed publisher
Zheng W, Zhang H, Zhao D, Zhang J, Pollard J. Lung Mammary Metastases but Not Primary Tumors Induce Accumulation of Atypical Large Platelets and Their Chemokine Expression. Cell Rep. 2019;29:1747-1755.e4 pubmed publisher
Haines R, Scharer C, Lobby J, Boss J. LSD1 Cooperates with Noncanonical NF-κB Signaling to Regulate Marginal Zone B Cell Development. J Immunol. 2019;203:1867-1881 pubmed publisher
Wang X, Sun G, Feng T, Zhang J, Huang X, Wang T, et al. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression. Cell Res. 2019;29:787-803 pubmed publisher
Putz E, Eder J, Reinhardt T, Sacco R, Casas E, Lippolis J. Differential phenotype of immune cells in blood and milk following pegylated granulocyte colony-stimulating factor therapy during a chronic Staphylococcus aureus infection in lactating Holsteins. J Dairy Sci. 2019;102:9268-9284 pubmed publisher
Hoppstädter J, Dembek A, Linnenberger R, Dahlem C, Barghash A, Fecher Trost C, et al. Toll-Like Receptor 2 Release by Macrophages: An Anti-inflammatory Program Induced by Glucocorticoids and Lipopolysaccharide. Front Immunol. 2019;10:1634 pubmed publisher
Fukumoto T, Fatkhutdinov N, Zundell J, Tcyganov E, Nacarelli T, Karakashev S, et al. HDAC6 Inhibition Synergizes with Anti-PD-L1 Therapy in ARID1A-Inactivated Ovarian Cancer. Cancer Res. 2019;79:5482-5489 pubmed publisher
Hole C, Wager C, Castro López N, Campuzano A, Cai H, Wozniak K, et al. Induction of memory-like dendritic cell responses in vivo. Nat Commun. 2019;10:2955 pubmed publisher
El Achkar G, Mrad M, Mouawad C, Badran B, Jaffa A, Motterlini R, et al. Heme oxygenase-1-Dependent anti-inflammatory effects of atorvastatin in zymosan-injected subcutaneous air pouch in mice. PLoS ONE. 2019;14:e0216405 pubmed publisher
Davidson T, Lee A, Hsu M, Sedighim S, Orpilla J, Treger J, et al. Expression of PD-1 by T Cells in Malignant Glioma Patients Reflects Exhaustion and Activation. Clin Cancer Res. 2019;25:1913-1922 pubmed publisher
Kaur A, Ecker B, Douglass S, Kugel C, Webster M, Almeida F, et al. Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility. Cancer Discov. 2019;9:64-81 pubmed publisher
Haines R, Barwick B, Scharer C, Majumder P, Randall T, Boss J. The Histone Demethylase LSD1 Regulates B Cell Proliferation and Plasmablast Differentiation. J Immunol. 2018;201:2799-2811 pubmed publisher
Alturki N, McComb S, Ariana A, Rijal D, Korneluk R, Sun S, et al. Triad3a induces the degradation of early necrosome to limit RipK1-dependent cytokine production and necroptosis. Cell Death Dis. 2018;9:592 pubmed publisher
Echevarría Vargas I, Reyes Uribe P, Guterres A, Yin X, Kossenkov A, Liu Q, et al. Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma. EMBO Mol Med. 2018;10: pubmed publisher
Maschmeyer P, Petkau G, Siracusa F, Zimmermann J, Zügel F, Kühl A, et al. Selective targeting of pro-inflammatory Th1 cells by microRNA-148a-specific antagomirs in vivo. J Autoimmun. 2018;89:41-52 pubmed publisher
Murayama G, Furusawa N, Chiba A, Yamaji K, Tamura N, Miyake S. Enhanced IFN-? production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Res Ther. 2017;19:234 pubmed publisher
Mathivet T, Bouleti C, Van Woensel M, Stanchi F, Verschuere T, Phng L, et al. Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growth. EMBO Mol Med. 2017;9:1629-1645 pubmed publisher
Fisher J, Abramowski P, Wisidagamage Don N, Flutter B, Capsomidis A, Cheung G, et al. Avoidance of On-Target Off-Tumor Activation Using a Co-stimulation-Only Chimeric Antigen Receptor. Mol Ther. 2017;25:1234-1247 pubmed publisher
Keller A, Eckle S, Xu W, Liu L, Hughes V, Mak J, et al. Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells. Nat Immunol. 2017;18:402-411 pubmed publisher
Allegrezza M, Rutkowski M, Stephen T, Svoronos N, Perales Puchalt A, Nguyen J, et al. Trametinib Drives T-cell-Dependent Control of KRAS-Mutated Tumors by Inhibiting Pathological Myelopoiesis. Cancer Res. 2016;76:6253-6265 pubmed
Philip N, DeLaney A, Peterson L, Santos Marrero M, Grier J, Sun Y, et al. Activity of Uncleaved Caspase-8 Controls Anti-bacterial Immune Defense and TLR-Induced Cytokine Production Independent of Cell Death. PLoS Pathog. 2016;12:e1005910 pubmed publisher
Peterson L, Philip N, Dillon C, Bertin J, Gough P, Green D, et al. Cell-Extrinsic TNF Collaborates with TRIF Signaling To Promote Yersinia-Induced Apoptosis. J Immunol. 2016;197:4110-4117 pubmed
Burel J, Apte S, Groves P, Klein K, McCarthy J, Doolan D. Reduced Plasmodium Parasite Burden Associates with CD38+ CD4+ T Cells Displaying Cytolytic Potential and Impaired IFN-γ Production. PLoS Pathog. 2016;12:e1005839 pubmed publisher
Rodriguez Garcia M, Shen Z, Barr F, Boesch A, Ackerman M, Kappes J, et al. Dendritic cells from the human female reproductive tract rapidly capture and respond to HIV. Mucosal Immunol. 2017;10:531-544 pubmed publisher
Palomo J, Mastelic Gavillet B, Woldt E, Troccaz S, Rodriguez E, Palmer G, et al. IL-36-Induced Toxicity in Neonatal Mice Involves TNF-? Production by Liver Myeloid Cells. J Immunol. 2016;197:2239-49 pubmed publisher
Souza Fonseca Guimaraes F, Krasnova Y, Putoczki T, Miles K, MacDonald K, Town L, et al. Granzyme M has a critical role in providing innate immune protection in ulcerative colitis. Cell Death Dis. 2016;7:e2302 pubmed publisher
Perales Puchalt A, Svoronos N, Rutkowski M, Allegrezza M, Tesone A, Payne K, et al. Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target. Clin Cancer Res. 2017;23:441-453 pubmed publisher
Tanaka Y, Nagashima H, Bando K, Lu L, Ozaki A, Morita Y, et al. Oral CD103-CD11b+ classical dendritic cells present sublingual antigen and induce Foxp3+ regulatory T cells in draining lymph nodes. Mucosal Immunol. 2017;10:79-90 pubmed publisher
Renshaw H, Vargas Muñiz J, Richards A, Asfaw Y, Juvvadi P, Steinbach W. Distinct Roles of Myosins in Aspergillus fumigatus Hyphal Growth and Pathogenesis. Infect Immun. 2016;84:1556-64 pubmed publisher
Shorter S, Schnell F, McMaster S, Pinelli D, Andargachew R, Evavold B. Viral Escape Mutant Epitope Maintains TCR Affinity for Antigen yet Curtails CD8 T Cell Responses. PLoS ONE. 2016;11:e0149582 pubmed publisher
Mittal D, Caramia F, Michiels S, Joensuu H, Kellokumpu Lehtinen P, Sotiriou C, et al. Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells. Cancer Res. 2016;76:264-74 pubmed publisher
Lombardi M, Gilliéron C, Dietrich D, Gabay C. SIK inhibition in human myeloid cells modulates TLR and IL-1R signaling and induces an anti-inflammatory phenotype. J Leukoc Biol. 2016;99:711-21 pubmed publisher
Zanvit P, Konkel J, Jiao X, Kasagi S, Zhang D, Wu R, et al. Antibiotics in neonatal life increase murine susceptibility to experimental psoriasis. Nat Commun. 2015;6:8424 pubmed publisher
DeFalco T, Potter S, Williams A, Waller B, Kan M, Capel B. Macrophages Contribute to the Spermatogonial Niche in the Adult Testis. Cell Rep. 2015;12:1107-19 pubmed publisher
Weiser J, Roche A, Hergott C, LaRose M, Connolly T, Jorgensen W, et al. Macrophage Migration Inhibitory Factor Is Detrimental in Pneumococcal Pneumonia and a Target for Therapeutic Immunomodulation. J Infect Dis. 2015;212:1677-82 pubmed publisher
Souza Fonseca Guimaraes F, Young A, Mittal D, Martinet L, Bruedigam C, Takeda K, et al. NK cells require IL-28R for optimal in vivo activity. Proc Natl Acad Sci U S A. 2015;112:E2376-84 pubmed publisher
Shade K, Platzer B, Washburn N, Mani V, Bartsch Y, Conroy M, et al. A single glycan on IgE is indispensable for initiation of anaphylaxis. J Exp Med. 2015;212:457-67 pubmed publisher
Keppel M, Saucier N, Mah A, Vogel T, Cooper M. Activation-specific metabolic requirements for NK Cell IFN-γ production. J Immunol. 2015;194:1954-62 pubmed publisher
Talabot Ayer D, Martin P, Vesin C, Seemayer C, Vigne S, Gabay C, et al. Severe neutrophil-dominated inflammation and enhanced myelopoiesis in IL-33-overexpressing CMV/IL33 mice. J Immunol. 2015;194:750-60 pubmed publisher
Nomura T, Yamamoto H, Shiino T, Takahashi N, Nakane T, Iwamoto N, et al. Association of major histocompatibility complex class I haplotypes with disease progression after simian immunodeficiency virus challenge in burmese rhesus macaques. J Virol. 2012;86:6481-90 pubmed publisher
Correia D, Fogli M, Hudspeth K, da Silva M, Mavilio D, Silva Santos B. Differentiation of human peripheral blood V?1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells. Blood. 2011;118:992-1001 pubmed publisher
Leonard J, Filzen T, Carter C, Schaefer M, Collins K. HIV-1 Nef disrupts intracellular trafficking of major histocompatibility complex class I, CD4, CD8, and CD28 by distinct pathways that share common elements. J Virol. 2011;85:6867-81 pubmed publisher
Ye Z, Lee C, Sun G, Gan Y. Burkholderia pseudomallei infection of T cells leads to T-cell costimulation partially provided by flagellin. Infect Immun. 2008;76:2541-50 pubmed publisher
Berg M, Zavazava N. Regulation of CD28 expression on CD8+ T cells by CTLA-4. J Leukoc Biol. 2008;83:853-63 pubmed
Magatti M, De Munari S, Vertua E, Gibelli L, Wengler G, Parolini O. Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities. Stem Cells. 2008;26:182-92 pubmed
Mitsuhashi M. Ex vivo simulation of drug action: quantification of drug-induced mRNA as a bridge between preclinical and clinical trials. Clin Chem. 2007;53:148-9 pubmed
Sheng W, Chen Y, Wang T. A major role of PKC theta and NFkappaB in the regulation of hTERT in human T lymphocytes. FEBS Lett. 2006;580:6819-24 pubmed
product information
Apps. Abbrev. :
Flow Cytometry
Cat # :
423103
Item :
Zombie Yellow™ Fixable Viability Kit
Other Names :
Fixable Dye, Fixable Viability Dye
Size :
100 tests
Price (USD) :
83 USD
Conjugate/Tag/Label :
NONAB_CHMPRB
Application Notes :
Standard Cell Staining Protocol: Prior to reconstitution, spin down the vial of lyophilized reagent in a microcentrofuge to ensure the reagent is at the bottom of the vial. For reconstitution, pre-warm the kit to room temperature; add 100 ul of DMSO to one vial of Zombie Yellow dye and mix until fully dissolved Wash cells with PBS buffer (no Tris buffer and protein free). Dilute Zombie Yellow dye at 1:100-1000 in PBS. Resuspend 1-10 x 10 6 cells in diluted 100 ul Zombie Yellow solution. To minimize background staining of live cells, titrate the amount of dye and/or number of cells per 100 ul for optimal performance. Different cell types can have a wide degree of variability in staining based on cell size and degree of cell death. Note: Don t use Tris buffer as a diluent and be sure that the PBS does not contain any other protein like BSA or FBS. Note: The amount of dye used can also influence the ability to detect apoptotic as well as live and dead cells. Incubate the cells at room temperature, in the dark, for 15-30 minutes. Wash one time with 2 ml BioLegend s Cell Staining Buffer (Cat. No. 420201) or equivalent buffer containing serum or BSA. Continue performing antibody staining procedure as desired. Cells can be fixed with paraformaldehyde or methanol prior to permeabilization or can be analyzed without fixation. . . No-wash Sequential Staining Protocol: . Wash cells with PBS buffer (no Tris buffer and protein free). For reconstitution, pre-warm the kit to room temperature; add 100 ul of DMSO to one vial of Zombie Yellow dye and mix until fully dissolved Determine the total ul volume of antibody cocktail previously titrated and optimized for the assay that will be added to each vial/well of cells based on a final volume of 100 ul. Subtract that antibody volume from the 100 ul total staining volume intended for the assay. In the remaining volume, dilute Zombie Yellow dye at 1:100-1000 in PBS as determined by prior optimization at that volume. For example, if you are adding 20 ul of antibody cocktail for a 100 ul total staining volume, use 80 ul of Zombie Yellow solution. Resuspend 1-10 x 10 6 cells in the appropriate volume of Zombie Yellow solution. Different cell types can have a wide degree of variability in staining based on cell size and degree of cell death. Note: Don t use Tris buffer as a diluent and be sure that the PBS does not contain any other protein like BSA or FBS. Note: The amount of dye used can also influence the ability to detect apoptotic as well as live and dead cells. Incubate for 10-15 minutes at RT, protected from light. Without washing the cells, add the cell surface antibody cocktail and incubate for another 15-20 minutes. Add 1-2 mL Cell Staining Buffer (Cat. No. 420201) or equivalent buffer containing BSA or serum. Centrifuge to pellet. Continue with normal fixation and permeabilization procedure. If planning to skip fixation and analyze cells live, complete an additional wash step to minimize any unnecessary background of the live cells. . Notes: If the cell type in use cannot tolerate a protein-free environment, then titrate the Zombie Yellow dye in the presence of the same amount of BSA/serum as will be present in the antibody staining procedure. A higher amount of Zombie Yellow may be required since the BSA/serum will react with and bind up some proportion of the Zombie Yellow . Zombie Yellow dye is excited by the violet laser and has a fluorescence emission maximum of 572 nm. If using in a multi-color panel design, filter optimization may be required depending on other fluorophores used. Zombie Yellow dye has similar emission to Brilliant Violet 570 .
company information
BioLegend
8999 BioLegend Way
San Diego, CA 92121
customerserv@biolegend.com
https://www.biolegend.com
headquarters: USA